SARS-CoV-2 Spike Protein and Neutralizing Anti-Spike Protein Antibodies Modulate Blood Platelet Function
International Journal of Molecular Sciences · 10.03.2023 · 24 (6) · 5312
DOI: 10.3390/ijms24065312 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 10.03.2023. Verfasst von Boguslawa Luzak und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hemostasis and Hemostatic Disorders, Medical University of Lodz, 92-215 Lodz, Poland. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Lodz, Medical University of Lodz, Poland.
Abstract (Originalsprache)
Several studies report elevated blood platelet activation and altered platelet count in COVID-19 patients, but the role of the SARS-CoV-2 spike protein in this process remains intriguing. Additionally, there is no data that anti-SARS-CoV-2 neutralizing antibodies (nAb) may attenuate spike protein activity toward blood platelets. Our results indicate that under in vitro conditions, the spike protein increased the collagen-stimulated aggregation of isolated platelets and induced the binding of vWF to platelets in ristocetin-treated blood. The spike protein also significantly reduced collagen- or ADP-induced aggregation or decreased GPIIbIIIa (fibrinogen receptor) activation in whole blood, depending on the presence of the anti-spike protein nAb. Our findings suggest that studies on platelet activation/reactivity in COVID-19 patients or in donors vaccinated with anti-SARS-CoV-2 and/or previously-infected COVID-19 should be supported by measurements of spike protein and IgG anti-spike protein antibody concentrations in blood.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hemostasis and Hemostatic Disorders, Medical University of Lodz, 92-215 Lodz, Poland.
- Department of Clinical Pharmacology, 1st Chair of Internal Diseases, Medical University of Lodz, 90-153 Lodz, Poland.
ORCID-Profile: Boguslawa Luzak, Marcin Rozalski, Tomasz Przygodzki, Magdalena Boncler, Dagmara Wojkowska, Marcin Kosmalski, Cezary Watala
Förderung
- Medical University of Lodz
- Medical University of Lodz, Poland
Zitieren
APA
Luzak, B., Rozalski, M., Przygodzki, T., Boncler, M., Wojkowska, D., Kosmalski, M., & Watala, C. (2023). SARS-CoV-2 Spike Protein and Neutralizing Anti-Spike Protein Antibodies Modulate Blood Platelet Function. International Journal of Molecular Sciences, 24(6), 5312. https://doi.org/10.3390/ijms24065312
Vancouver
Luzak B, Rozalski M, Przygodzki T, Boncler M, Wojkowska D, Kosmalski M, et al. SARS-CoV-2 Spike Protein and Neutralizing Anti-Spike Protein Antibodies Modulate Blood Platelet Function. International Journal of Molecular Sciences. 2023;24(6):5312. doi:10.3390/ijms24065312
BibTeX
@article{Luzak2023,
author = {Luzak, Boguslawa and Rozalski, Marcin and Przygodzki, Tomasz and Boncler, Magdalena and Wojkowska, Dagmara and Kosmalski, Marcin and Watala, Cezary},
title = {SARS-CoV-2 Spike Protein and Neutralizing Anti-Spike Protein Antibodies Modulate Blood Platelet Function},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {6},
pages = {5312},
doi = {10.3390/ijms24065312}
}
EUVIMED